Acadian Asset Management
CELU icon

Acadian Asset Management’s Celularity CELU Stock Holding History

Acadian Asset Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,565
Closed -$24K – 1841
2025
Q2 		$24K Sell
12,565
-7,593
-38% -$13.8K ﹤0.01% 1566
2025
Q1 		$34K Buy
+20,158
New +$38.2K ﹤0.01% 1481

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Acadian Asset Management's CELU Position: Q3 2025 in Review

Acadian Asset Management sold out of Celularity (CELU) in Q3 2025, closing a stake of 12,565 shares — an estimated $24K sold.

Acadian Asset Management first reported a position in CELU in Q1 2025 and held it in 2 quarters. The position peaked at $34K in Q1 2025. 38 funds tracked by Wall St. Rank hold CELU as of Q3 2025.

  • Acadian Asset Management reported no remaining Celularity position as of Q3 2025 after selling out during the quarter.
  • Acadian Asset Management sold 12,565 Celularity shares in Q3 2025, an estimated $24K.
  • Acadian Asset Management first reported a position in Celularity in Q1 2025 and held it in 2 quarters.
  • Acadian Asset Management's Celularity position peaked at $34K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q3 2025.

Based on Acadian Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.